Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
- 1 March 2001
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 87 (6), 815-818
- https://doi.org/10.1016/s0002-9149(00)01516-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokinesClinical Transplantation, 2000
- Stimulation of Bone Formation in Vitro and in Rodents by StatinsScience, 1999
- MODULATION OF CORONARY VASOMOTOR TONE BY CYTOKINES IN CARDIAC TRANSPLANT RECIPIENTSTransplantation, 1999
- The TNF-α system in heart failure and after heart transplantation; plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacityEuropean Heart Journal, 1999
- Inhibition of proinflammatory cytokine production by pravastatinThe Lancet, 1999
- Increased Bioavailability of Nitric Oxide After Lipid-Lowering Therapy in Hypercholesterolemic PatientsCirculation, 1998
- Pathophysiologically Relevant Concentrations of Tumor Necrosis Factor-α Promote Progressive Left Ventricular Dysfunction and Remodeling in RatsCirculation, 1998
- Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDMDiabetologia, 1995
- Close relation of endothelial function in the human coronary and peripheral circulationsJournal of the American College of Cardiology, 1995
- Serum Levels of Tumor Necrosis Factor- (TNF ) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic ParametersThe Journal of Infectious Diseases, 1994